Airless Dispensing – an Opportunity for Brands
Sponsored by: Aptar Pharma
Date: 6 July
Days to go: 23
Time: 3:30PM London/4:30PM Paris/10:30AM New York
Dermal Drug Delivery for the Future
The concept of Airless drug delivery systems in dermatology isn’t new. It’s a recognised device technology in topical and transdermal drug delivery for semisolids like gels, creams and ointments. This device technology has clear benefits in safety, reliability, convenience, and patient experience, but has not yet witnessed the universal adoption one would have expected.
This webinar on Airless dispensing will review the current market and available technologies. It will also discuss the benefits of Airless pump technology in topical drug development, manufacturing and the end user, leading to commercial success.
Recognizing the changing regulatory environment of drug development, we will share how acknowledged medical device manufacturers can help with their expertise. Aptar Pharma’s extended support helps access the benefits of airless drug delivery systems and to successfully develop new dermal drug products.
We will also introduce connecting airless drug delivery to the growing trend of digital healthcare and disease management.
Register today and learn more insights how Airless drug delivery systems are creating new opportunities in topical and transdermal drug delivery.
Dr Stefan Hellbardt,
Vice President Business Development and Scientific Affairs, Aptar Pharma
Product Manager Airless CHC, Aptar Pharma
Director Business Development, Digital Health, Aptar Pharma
Key Learning Objectives
- Overview of the Airless device market and its opportunity for dermal brands
- Understand Airless technology
- Understand the value of Airless drug delivery for pharmaceutical companies and their patients
- Discover the benefits of partnering with the “go-to” drug delivery expert
- Packaging R&D
- Project Management
- Brand Management
- Fill / Finish Operations
- Consumer Relation